glucura
Commercial- Indications
- Type 2 diabetes
Company intelligence / Profile preview
Perfood offers a digital therapeutic solution via its "glucura" app that provides personalized dietary recommendations to help users control their blood glucose levels. The approach focuses on individualized responses to foods and lifestyle changes for sustainable metabolic improvements. Clinical results are not detailed in the provided sources but user testimonials suggest positive outcomes in glycemic control and weight management without side effects or restrictive dieting. No published clinical trial data found in the search results. The company positions itself as a science-driven team with expertise across nutrition science and digital health. The product appears commercially available rather than investigational. Pipeline breadth cannot be determined precisely; only one main program/app ("glucura") described.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Perfood.